121 related articles for article (PubMed ID: 11996485)
41. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.
Hong WK; Nicaise C; Lawson R; Maroun JA; Comis R; Speer J; Luedke D; Hurtubise M; Lanzotti V; Goodlow J
J Clin Oncol; 1989 Apr; 7(4):450-6. PubMed ID: 2538577
[TBL] [Abstract][Full Text] [Related]
42. [Alternating chemotherapeutic treatment in patients with localized undifferentiated small-cell carcinoma of the lung].
Navarro M; Mur E; Jolis L; Bellmunt J; Bodi R; Solé LA; Rubio D
Rev Clin Esp; 1991 Oct; 189(5):209-12. PubMed ID: 1666192
[TBL] [Abstract][Full Text] [Related]
43. Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
Gilbert C; Meisenberg B; Vredenburgh J; Ross M; Hussein A; Perfect J; Peters WP
J Clin Oncol; 1994 May; 12(5):1005-11. PubMed ID: 8164024
[TBL] [Abstract][Full Text] [Related]
44. Extensive stage small cell lung cancer: determining suitability for outpatient management of febrile neutropenia.
Rapp JS; Perry MC; Rotche RM
Semin Oncol; 1996 Apr; 23(2):xv-xxii; discussion xxii. PubMed ID: 8623054
[No Abstract] [Full Text] [Related]
45. Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study.
von Minckwitz G; Kümmel S; du Bois A; Eiermann W; Eidtmann H; Gerber B; Hilfrich J; Huober J; Costa SD; Jackisch C; Grasshoff ST; Vescia S; Skacel T; Loibl S; Mehta KM; Kaufmann M;
Ann Oncol; 2008 Feb; 19(2):292-8. PubMed ID: 17846019
[TBL] [Abstract][Full Text] [Related]
46. Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer.
Figueredo AT; Hryniuk WM; Strautmanis I; Frank G; Rendell S
J Clin Oncol; 1985 Jan; 3(1):54-64. PubMed ID: 2981292
[TBL] [Abstract][Full Text] [Related]
47. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
[TBL] [Abstract][Full Text] [Related]
48. Cyclic alternating chemotherapy for small cell carcinoma of the lung.
Murray N; Shah A; Wilson K; Goldie J; Voss N; Fryer C; Klimo P; Coy P; Hadzic E; Gudauskas G
Cancer Treat Rep; 1985 Nov; 69(11):1241-2. PubMed ID: 3004724
[TBL] [Abstract][Full Text] [Related]
49. Adjuvant chemotherapy with TAC (docetaxel, doxorubicin, and cyclophosphamide) in patients with breast cancer--incidence of neutropenic fever outside clinical trials.
Passos-Coelho JL; Esteves S; Vieira PA; Isidoro M; Ribeiro M; Oliveira J; Moreira AR
Breast J; 2011; 17(5):539-41. PubMed ID: 21899649
[No Abstract] [Full Text] [Related]
50. Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC Lung Cancer Working Party (Belgium).
Klastersky J; Sculier JP; Dumont JP; Becquart D; Vandermoten G; Rocmans P; Michel J; Longeval E; Dalesio O
Cancer; 1985 Jul; 56(1):71-5. PubMed ID: 2988738
[TBL] [Abstract][Full Text] [Related]
51. Alternating chemotherapy with or without VP-16 in extensive-stage small-cell lung cancer.
Everson LK; Jett JR; O'Fallon JR; Krook JE; Dalton RJ; Mailliard JA; Tschetter LK; Cullinan SA; Gerstner JB; Morton RF
Am J Clin Oncol; 1989 Aug; 12(4):339-44. PubMed ID: 2547304
[TBL] [Abstract][Full Text] [Related]
52. Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide.
Jones AL; Holborn J; Ashley S; Smith IE
Eur J Cancer; 1991; 27(7):866-70. PubMed ID: 1657078
[TBL] [Abstract][Full Text] [Related]
53. The impact of Filgrastim schedule variation on hematopoietic recovery post-chemotherapy.
Crawford J; Kreisman H; Garewal H; Jones SE; Shoemaker D; Pupa MR; Armstrong S; Tomita D; Dziem G
Ann Oncol; 1997 Nov; 8(11):1117-24. PubMed ID: 9426331
[TBL] [Abstract][Full Text] [Related]
54. Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in adolescents.
Shiu JR; Romanick M; Stobart K
Pediatr Blood Cancer; 2009 Dec; 53(7):1357; author reply 1358. PubMed ID: 19492324
[No Abstract] [Full Text] [Related]
55. Dose intensity phase I/II trial with carboplatin, ifosfamide, etoposide and vincristine combined with filgrastim in patients with small-cell lung cancer.
Hanauske AR; Korfel A; Perker M; Heinrich B; Schwab G; Graf M; Depenbrock H; Höffken G; Kreuser ED; Thiel E; Zwingers T; Berdel WE
Oncology; 1997; 54(5):363-70. PubMed ID: 9260596
[TBL] [Abstract][Full Text] [Related]
56. Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.
Einhorn LH; Crawford J; Birch R; Omura G; Johnson DH; Greco FA
J Clin Oncol; 1988 Mar; 6(3):451-6. PubMed ID: 2832549
[TBL] [Abstract][Full Text] [Related]
57. Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib study.
D'Hondt V; Weynants P; Humblet Y; Guillaume T; Canon JL; Beauduin M; Duprez P; Longueville J; Müll R; Chatelain C
J Clin Oncol; 1993 Nov; 11(11):2063-71. PubMed ID: 8229120
[TBL] [Abstract][Full Text] [Related]
58. Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.
Gomez-Martin C; Solá C; Hornedo J; Perea S; Lumbreras C; Valentí V; Arcediano A; Rodriguez M; Salazar R; Cortés-Funes H; Hidalgo M
J Clin Oncol; 2000 May; 18(10):2126-34. PubMed ID: 10811678
[TBL] [Abstract][Full Text] [Related]
59. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
[TBL] [Abstract][Full Text] [Related]
60. Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma.
Wood L; Palmer M; Hewitt J; Urtasun R; Bruera E; Rapp E; Thaell JF
Br J Cancer; 1998 Feb; 77(4):627-31. PubMed ID: 9484821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]